The pharmaceutical manufacturing landscape for oral mesalazine has undergone substantial transformation, driven by technological advancements, regulatory evolution, and the imperative for supply chain resilience. As a mature active pharmaceutical ingredient with established synthetic routes, mesalazine production might appear straightforward, yet contemporary manufacturing demands extend far...